Lilly, Boehringer launch combo diabetes pill; Anti-counterfeiting bill gains steam on phony Avastin news;

@FiercePharma: More OTC drugs? FDA may allow more meds to go non-prescription. Consumer-use studies still required. Story | Follow @FiercePharma

> Eli Lilly ($LLY) and Boehringer Ingelheim launched their new combo drug Jentadueto--which comprises BI's Tradjenta and the commonly used generic metformin--in the U.S. Report

> Amag Pharmaceuticals ($AMAG) said its Feraheme anemia treatment, now targeted at patients with chronic kidney disease, worked as well as standard therapy in patients with cancer, gastrointestinal problems and abnormal uterine bleeding. News

> An anti-counterfeiting bill has gathered fresh steam on news of phony Avastin surfacing in the U.S. supply chain. Item

> Pinpointing the genetic characteristics of cancers is complicated, best done with multiple samples and repeatedly, during treatment, to make sure the correct drugs are used to target tumors, a study found. More

> Almac Pharma Services is moving deeper into the U.S. market with a new, $10 million commercial packaging operation in Audubon, PA. Piece

> FDA released new draft guidance for classifying post-marketing safety issues, designed to help the agency better prioritize its responses. Report

Biotech News

@FierceBiotech: Navy maneuvers to bombard dengue fever in vaccine study. Story | Follow @FierceBiotech

@JohnCFierce: J&J wows analysts with early success of Zytiga Ph3 for prostate cancer. News | Follow @JohnCFierce

@RyanMFierce: Props to Bellicum Pharma, not only for the new $20M B round, but also for the transparent explanation of the deal. Release | Follow @RyanMFierce

> NeurogesX slashes staff, shifts R&D direction after FDA slaps down app. News

> Promedior lands $21.5M D round for fibrosis pipeline. Article

> Bellicum snags $20M for cancer vaccine program. Item

Manufacturing News

> AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others. Item

> Almac builds on U.S. expansion with $10M pharmaceutical packaging plant. Article

CRO News

> Biosimilars growth draws contract labs into the fray. More

> Survey: Look for strong growth in R&D outsourcing, shift to India and China. Report

> Frustrated Pfizer seeks Euro recruitment contractor for 'virtual' trial. Article

> Survey zeroes in on CRO frustrations. Item

Vaccines News

> Is Agenus on GSK's shopping list? More

> Inovio vaccine targets head and neck HPV subtypes. Report

> Gradalis' personalized cancer vaccine has FANGs. Story

> Microneedles trigger better responses to flu vaccine. Article

And Finally... After a crackdown on pill mills, Florida's pain-drug trade has moved to retail pharmacies. Article